Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to the Tarsus’ Second Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Tang Capital Management Kevin C. Tang | 2,254,797 | $61,285,382 | 6.24% | |
2. | Perceptive Advisors Joseph Edelman | 1,296,416 | $35,236,587 | 0.84% | |
3. | Ikarian Capital Neil Shahrestani | 800,277 | $21,751,529 | +13% | 3.78% |
4. | Integral Health Asset Management Bhagwan Jay Rao | 590,000 | $16,036,200 | 1.52% | |
5. | Vivo Capital Albert Cha And Frank Kung | 565,550 | $15,371,649 | 1.41% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$18.96 | 1,000 | Director | 3,000 | 2023-12-15 | Filing | |
$16.80 | 9,506 | Director | 15,866 | 2023-08-15 | Filing | |
$16.29 | 6,360 | Director | 6,360 | 2022-09-14 | Filing | |
$16.03 | 12,040 | Director | 12,040 | 2022-09-14 | Filing | |
$13.50 | 100,000 | Director | 100,000 | 2022-05-05 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$26.53 | 5,021 | 0 | 2024-08-12 | Filing | ||
$26.01 | 29,979 | 5,021 | 2024-08-12 | Filing | ||
$27.47 | 10,445 | Officer | 18,136 | 2024-06-18 | Filing | |
$30.60 | 4,766 | Officer | 54,075 | 2024-03-18 | Filing | |
$30.60 | 4,436 | Officer | 40,951 | 2024-03-18 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 3,152,341 | $63,834,905 | 0.99% | |
2. | 2,516,139 | $50,951,816 | 0% | |
3. | 1,957,688 | $39,643,184 | 0% | |
4. | 1,911,399 | $38,705,829 | 2.53% | |
5. | 1,787,527 | $36,197,422 | 1.93% |